DaVita (NYSE:DVA) Announces Earnings Results, Beats Expectations By $0.10 EPS

DaVita (NYSE:DVA) posted its earnings results on Thursday. The company reported $2.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10, Zacks reports. DaVita had a return on equity of 88.18% and a net margin of 6.53%. DaVita updated its FY 2025 guidance to 10.200-11.300 EPS.

DaVita Stock Performance

NYSE:DVA opened at $177.45 on Friday. The stock’s 50-day moving average is $161.47 and its 200-day moving average is $157.25. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78. The stock has a market cap of $14.55 billion, a P/E ratio of 19.14, a price-to-earnings-growth ratio of 0.84 and a beta of 0.94. DaVita has a 1-year low of $118.56 and a 1-year high of $179.60.

Wall Street Analysts Forecast Growth

Separately, Barclays raised their price target on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, DaVita has an average rating of “Hold” and a consensus price target of $161.80.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.